For the first time, tinnitus was found to be very common in cancer survivors – SFGATE

Scientists in San Francisco They first discovered that hearing loss and tinnitus are extremely common in survivors of the four most common types of cancer.

in the results, posted this week, University of California, San Francisco researchers found that more than half of the survivors in the study who underwent chemotherapy had significant hearing problems.

Currently, adults who are undergoing treatment for the most common types of cancer — breast, gastrointestinal, gynecological, or lung cancer — do not routinely have hearing tests. The study authors suggest that this needs to change.

Of the 273 cancer survivors in the study who completed cancer treatment about 5 years ago, more than 50% experienced significant hearing loss and 35% reported tinnitus — a ringing or buzzing in the ears.

Stephen W. Cheung, a professor at the University of California, San Francisco, said: the report.


It was previously known that platinum drugs used to treat testicular and head and neck cancers led to hearing loss, but the study found that another class of chemotherapy drugs called taxanes also caused harm.

“Given that platinum- and taxane-containing chemotherapy regimens are most commonly used to treat the majority of cancers, these findings have tremendous implications for clinicians treating cancer patients, as well as for cancer survivors,” Cheung wrote.

Study participants with hearing loss reported impairment during routine activities such as listening to television, talking to family and in restaurants. Those with tinnitus said the problem affected their ability to relax, focus, sleep and enjoy life.

The study found that only 17% of participants wore hearing aids, and it urged doctors to refer all cancer survivors for hearing tests.

“While individuals often underestimate hearing problems, our findings suggest that cancer survivors need to have their hearing tested,” wrote corresponding author Kristen Myaskowski.

#time #tinnitus #common #cancer #survivors #SFGATE

Leave a Comment

Your email address will not be published.